AEON Biopharma, Inc.
Related Filers (1)
Other (5)
D/A
Thursday, 5/13/2021
Exempt (Private) Offering
D
Monday, 8/31/2020
Exempt (Private) Offering
D
Wednesday, 8/10/2016
Exempt (Private) Offering
D
Friday, 11/20/2015
Exempt (Private) Offering
D
Thursday, 1/22/2015
Exempt (Private) Offering
Ownership (11)
SC 13G/A
Friday, 1/17/2020
Evolus, Inc.: Major Shareholders
4
Friday, 1/10/2020
Evolus, Inc.: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 6/4/2019
Evolus, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/4/2019
Evolus, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/22/2019
Evolus, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 2/14/2019
Evolus, Inc.: Major Shareholders
4
Monday, 12/3/2018
Evolus, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/13/2018
Evolus, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/23/2018
Evolus, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/13/2018
Evolus, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/7/2018
Evolus, Inc.: Initial statement of beneficial ownership of securities
Prospectus (11)
RW
Wednesday, 12/29/2021
Registration Withdrawal Request
S-1/A
Thursday, 10/7/2021
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Wednesday, 10/6/2021
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Monday, 10/4/2021
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 9/17/2021
General form of registration statement for all companies including face-amount certificate companies
DRS/A
Tuesday, 9/14/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS/A
Wednesday, 7/21/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS/A
Tuesday, 6/8/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS/A
Monday, 3/23/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS/A
Wednesday, 2/12/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Friday, 12/27/2019
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy